Endocannabinoids and Lipid Mediators in Brain Functions

The science of cannabinoids is 50 years old. These past years provided a remarkable and constant number of breakthroughs, showing that the signaling mediated by endocannabinoids and lipid mediators impacts almost every function of the body. Indeed, this represents a special field of research, which...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Melis, Miriam (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04379nam a22004575i 4500
001 978-3-319-57371-7
003 DE-He213
005 20170531021649.0
007 cr nn 008mamaa
008 170530s2017 gw | s |||| 0|eng d
020 |a 9783319573717  |9 978-3-319-57371-7 
024 7 |a 10.1007/978-3-319-57371-7  |2 doi 
040 |d GrThAP 
050 4 |a RC321-580 
072 7 |a PSAN  |2 bicssc 
072 7 |a MED057000  |2 bisacsh 
082 0 4 |a 612.8  |2 23 
245 1 0 |a Endocannabinoids and Lipid Mediators in Brain Functions  |h [electronic resource] /  |c edited by Miriam Melis. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2017. 
300 |a XII, 372 p. 26 illus., 19 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a - The Endocannabinoid System in Leptin-Driven Changes of Orexinergic Signalling Under Physiological and Pathological Conditions -- How CB1 Receptor Activity and Distribution Contribute to Make the Male and Female Brain Different Towards Cannabinoid-Induced Effects -- Endocannabinoids, Stress, and Negative Affect -- Cell-Autonomous Endocannabinoid Production Shapes Polarized and Dynamic Distribution and Signaling Patterns of Cannabinoid CB1 Receptors in Neurons -- Endocannabinoid-Dependent Synaptic Plasticity in Striatum -- Lipid Mediators in the Regulation of Emotions, Memory and Cognitive Functions -- The Endocannabinoid System in Prefrontal Synaptopathies -- Cannabinoids and Mitochondria -- Endocannabinoids and Lipid Mediators in Brain Function -- Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology -- Roles of N-Acylethanolamines in Brain Functions and Neuropsychiatric Diseases -- Mast Cells and Glia as Targets for the Anandamide Congener Palmitoylethanolamide, and Anti-Inflammatory and Neuroprotective Lipid-Signaling Molecule. 
520 |a The science of cannabinoids is 50 years old. These past years provided a remarkable and constant number of breakthroughs, showing that the signaling mediated by endocannabinoids and lipid mediators impacts almost every function of the body. Indeed, this represents a special field of research, which allows tackling the complexity of biological functions, and provides potential therapeutic frameworks for a plethora of diseases. The number of exciting discoveries brought up to the scientific community almost on a daily basis highlights the importance of an updated volume on this topic. Particularly, given that potential therapeutic benefits of cannabis and cannabinoids are currently under heavy analysis in many Countries worldwide. Hence, the main objective of this book is to explore not only some of the many functions of endocannabinoids (and lipid mediators) in physiological control of networks at a cellular and molecular level, but also to extend this knowledge for potential use of cannabinoids and/or drugs regulating endocannabinoid levels in vivo as therapeutic target(s) in neurological and neuropsychiatric disorders. In this book new findings and ideas about the endocannabinoid system and its roles as neuronal circuit modulator related to human brain pathologies characterized by alterations in neuroplasticity will be highlighted. Endocannabinoid roles in key systems controlling appetite, pain, learning and memory, as well as sleep and stress responses will be presented. In addition, pathological processes associated with changes in endocannabinoid signaling will be discussed in the context of anxiety, autism, depression and addiction. This book will provide an excellent background to researchers looking for extending their areas of interest, and to newcomers in the field. 
650 0 |a Medicine. 
650 0 |a Neurosciences. 
650 0 |a Pharmacology. 
650 0 |a Psychopharmacology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Neurosciences. 
650 2 4 |a Psychopharmacology. 
650 2 4 |a Pharmacology/Toxicology. 
700 1 |a Melis, Miriam.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319573694 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-57371-7  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)